STRS Ohio’s VYNE Therapeutics VYNE Stock Holding History

STRS Ohio’s Portfolio VYNE Stock Details VYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-504	Closed	-$60K	–	2288
2020 Q3	$60K	Buy	+504	New	+$58.8K	﹤0.01%	1936
2018 Q2	–	Sell	-25	Closed	-$67K	–	2185
2018 Q1	$67K	Buy	+25	New	+$60.8K	﹤0.01%	1686

Other funds holding VYNE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAM

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

STRS Ohio's VYNE Position: Q4 2020 in Review

STRS Ohio sold out of VYNE Therapeutics (VYNE) in Q4 2020, closing a stake of 504 shares — an estimated $60K sold.

STRS Ohio first reported a position in VYNE in Q1 2018 and held it in 2 quarters. The position peaked at $67K in Q1 2018. 104 funds tracked by Wall St. Rank hold VYNE as of Q4 2020.

STRS Ohio reported no remaining VYNE Therapeutics position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 504 VYNE Therapeutics shares in Q4 2020, an estimated $60K.
STRS Ohio first reported a position in VYNE Therapeutics in Q1 2018 and held it in 2 quarters.
STRS Ohio's VYNE Therapeutics position peaked at $67K in Q1 2018.
104 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.